Merck's SWOT analysis: pharma giant's stock faces China setback, PAH potential
(NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial hypertension ...
Medical Design and Outsourcing11h
Medtronic’s Project Gemini for next-gen renal denervation has a new target
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
Link between hypertension and the gut could pave way to better high blood pressure drugs
Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...
Pulmonaryhypertensionnews.com18h
Right heart size differs between men and women with PAH: Study
Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...
Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...